Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 610 (ZNF610) is a protein-coding gene predicted to encode a DNA-binding transcription factor that is active in the nucleus and may be involved in the regulation of transcription by RNA polymerase II[2][5][6][8]. ZNF610 belongs to the family of zinc finger proteins, the largest group of transcription factors in the human genome, which are characterized by their finger-like DNA-binding motifs and are involved in diverse cellular processes such as gene expression, cell differentiation, and apoptosis[1][5]. No specific drug interactions, biomarker roles, or disease relevance have been reported for ZNF610, and it is not recognized as a direct therapeutic target at this time[5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 610 (ZNF610).